Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation

Bone Marrow Transplantation

Volumn 26, Issue 12, 2000, Pages 1333-1338

  Baldwin, A ^a   Kingman, H ^a   Darville, M ^b   Foot, A B M ^a   Grier, D ^c   Cornish, J M ^a   Goulden, N ^a   Oakhill, A ^a   Pamphilon, D H ^a   Steward, C G ^a   Marks, D I ^a  

^a Bone Marrow Transplant Unit   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adenovirus; Bone marrow transplantation; Diarrhoea; Pneumonitis

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BACTERIAL TOXIN; BILIRUBIN; BUSULFAN; CARMUSTINE; CIDOFOVIR; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOUBLE STRANDED DNA; ETOPOSIDE; GANCICLOVIR; HLA ANTIGEN; HUMAN IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; ITRACONAZOLE; MELPHALAN; METHOTREXATE; PENICILLIN V; RIBAVIRIN; STEROID; VIRUS DNA;

ADENOVIRUS; ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIARRHEA; DISEASE SEVERITY; DONOR; FECES ANALYSIS; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; INCIDENCE; INFANT; LEUKOCYTE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPING; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS ISOLATION;

ADENOVIRUS INFECTIONS, HUMAN; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIARRHEA; FEMALE; FEVER; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; TREATMENT OUTCOME;

EID: 17744362865     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702716     Document Type: Article

References (22)

1. Allogeneic bone marrow transplantation for chronic myeloid leukaemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years
2. Other viruses after bone marrow transplantation
3. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic bone marrow transplantation
4. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
5. Adenovirus infection in patients undergoing bone marrow transplantation
6. Viral infections in pediatric bone marrow transplant patients
7. Increasing incidence of adenovirus disease in bone marrow transplant recipients
8. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation
9. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir
10. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children
11. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission
12. Children with acute lymphoblastic leukemia who receive T cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome
13. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors
14. Chronic graft-versus-host syndrome in man. A long-term clinicopathological study of 20 Seattle patients
15. Fatal adenovirus 32 infection in a bone marrow transplant recipient
16. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications
17. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient
18. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation
19. Adenovirus infection after pediatric bone marrow transplantation
20. Virus recovery from stools of patients undergoing bone marrow transplantation
21. Infectious gastroenteritis in bone marrow transplant recipients
22. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor